Literature DB >> 8634575

Developing a policy on osteoporosis. Clinical risk factors alone are insufficient in decision making.

P Selby, M Davies.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8634575      PMCID： PMC2350947          DOI： 10.1136/bmj.312.7040.1225a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Department of Health shoots itself in the hip. Why the report of the Advisory Group on Osteoporosis undermines evidence based purchasing.

Authors:  T A Sheldon; A Raffle; I Watt
Journal:  BMJ       Date:  1996-02-03

2.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

3.  Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group.

Authors:  C Cooper; S Shah; D J Hand; J Adams; J Compston; M Davie; A Woolf
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.